Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion
Authors:
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Kidney Medicine
- Vol. 3 (4) , 619-634
Abstract
No abstract availableKeywords
Funding Information
- Amgen
- Kyowa Kirin Pharmaceutical Development
- Astellas Pharma US
- Chulalongkorn University
- AstraZeneca
- Novo Nordisk
- GlaxoSmithKline
- Vifor Pharma
- Boehringer Ingelheim
- Fresenius Medical Care North America
- FibroGen
This publication has 28 references indexed in Scilit:
- Global Dialysis Perspective: ThailandKidney360, 2020
- A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infectionKidney International, 2020
- Peritoneal Dialysis During the Coronavirus Disease-2019 (COVID-19) Pandemic: Acute Inpatient and Maintenance Outpatient ExperiencesKidney Medicine, 2020
- Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, ChinaJournal of the American Society of Nephrology, 2020
- Alta prevalencia de COVID-19 asintomático en hemodiálisis. Aprendiendo día a día el primer mes de pandemia de COVID-19Nefrología, 2020
- Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplantNefrología (English Edition), 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centresNephrology Dialysis Transplantation, 2020
- Mitigating Risk of COVID-19 in Dialysis FacilitiesClinical Journal of the American Society of Nephrology, 2020
- Toward a science of learning systems: a research agenda for the high-functioning Learning Health SystemJournal of the American Medical Informatics Association, 2014